EVEROLIMUS®
Generic name: EVEROLIMUS
Dosage form: Tablet
Strength: 5 mg
Indication: Breast Cancer, Renal Cell
Carcinoma, Advanced Neuroendocrine Tumors, Renal Angiomyolipoma, Subependymal Giant Cell Astrocytoma